Ftse Mib
35.398,82
-0,03%
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
NASDAQ
16.685,97
-0,07%
Bitcoin
66.955,84
-0,19%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. AMEX Biosante Pharmaceuticals (BPA) Biosante Pharmaceuticals (BPA) Notizie

BPA

Biosante Pharma (BPA)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:BPA
DataOraFonteTitoloSimboloCompagnia
31/10/200722:21Edgar (US Regulatory)Biosante Pharmaceuticals Inc - Amended Securities Registration (section 12(b)) (8-A12B/A)AMEX:BPABiosante Pharmaceuticals
24/10/200717:23Edgar (US Regulatory)Biosante Pharmaceuticals Inc - Current report filing (8-K)AMEX:BPABiosante Pharmaceuticals
24/10/200717:23Edgar (US Regulatory)Biosante Pharmaceuticals Inc - Current report filingAMEX:BPABiosante Pharmaceuticals
24/09/200719:57PR Newswire (US)WallSt.net Announces Upcoming Interview with CEO of BioSante PharmaceuticalsAMEX:BPABiosante Pharmaceuticals
14/08/200722:15Business WireBioSante Pharmaceuticals Reports Second Quarter 2007 Financial ResultsAMEX:BPABiosante Pharmaceuticals
08/08/200714:00Business WireBioSante Pharmaceuticals to Present at Upcoming ConferencesAMEX:BPABiosante Pharmaceuticals
25/07/200714:00Business WireBioSante Pharmaceuticals Announces Positive Results for its CaP Technology for Use in Aesthetic MedicineAMEX:BPABiosante Pharmaceuticals
11/07/200714:00Business WireBioSante Pharmaceuticals Announces New Findings for Potential Bird Flu VaccineAMEX:BPABiosante Pharmaceuticals
10/07/200713:00PR Newswire (US)WallSt.net (www.wallst.net ) Updates the Investment Community Through All-New Interviews with BPA, PPCO and NVAXAMEX:BPABiosante Pharmaceuticals
28/06/200713:00Business WireBioSante Pharmaceuticals, Inc. Joins Russell Microcap IndexAMEX:BPABiosante Pharmaceuticals
19/06/200714:00Business WireBioSante Pharmaceuticals Announces Oral Contraceptive Phase II Study InitiationAMEX:BPABiosante Pharmaceuticals
14/06/200714:00Business WireBioSante Pharmaceuticals Completes $18.3 Million Private Placement of Common StockAMEX:BPABiosante Pharmaceuticals
13/06/200714:45PR Newswire (US)Bradley Pharmaceuticals Announces Launch of Elestrin(TM)AMEX:BPABiosante Pharmaceuticals
25/05/200715:26Business WireBioSante Pharmaceuticals Announces $16.5 Million Private Placement of Common StockAMEX:BPABiosante Pharmaceuticals
07/05/200714:00Business WireBioSante Pharmaceuticals Signs Oral Contraceptive License with Pantarhei BioscienceAMEX:BPABiosante Pharmaceuticals
04/05/200714:45PR Newswire (US)Bradley Pharmaceuticals to Preview New Products at ACOG MeetingAMEX:BPABiosante Pharmaceuticals
01/05/200723:00Business WireBioSante Pharmaceuticals Reports First Quarter 2007 Financial ResultsAMEX:BPABiosante Pharmaceuticals
11/04/200714:45PR Newswire (US)Bradley Pharmaceuticals' Elestrin(TM) Receives New Patent to 2022AMEX:BPABiosante Pharmaceuticals
10/04/200714:00Business WireBioSante Pharmaceuticals Announces Issuance of New Patent Covering Elestrin(TM) and LibiGel(R)AMEX:BPABiosante Pharmaceuticals
02/04/200720:09PR Newswire (US)Dawson James Securities Reiterates Strong Buy Recommendation on Antares Pharma (Amex: AIS) with $4.00 Price TargetAMEX:BPABiosante Pharmaceuticals
26/03/200713:30Business WireBioSante Pharmaceuticals Receives Milestone Payment from Bradley PharmaceuticalsAMEX:BPABiosante Pharmaceuticals
08/03/200722:34Business WireBioSante Pharmaceuticals Reports Net Profit of $2.8 million for 2006 And Investor Conference CallAMEX:BPABiosante Pharmaceuticals
30/01/200714:00Business WireBioSante Pharmaceuticals Announces Positive Bird Flu Results Using Proprietary Vaccine Adjuvant in Pre-Clinical StudyAMEX:BPABiosante Pharmaceuticals
16/01/200715:00Business WireStephen M. Simes, President and CEO of BioSante Pharmaceuticals, Inc., Talks to The Wall Street TranscriptAMEX:BPABiosante Pharmaceuticals
19/12/200613:45PR Newswire (US)Bradley Pharmaceuticals Announces FDA Approval of Elestrin(TM) (estradiol gel 0.06%)AMEX:BPABiosante Pharmaceuticals
04/12/200614:00Business WireBioSante Pharmaceuticals to Present at Upcoming Biotech/Specialty Pharma and Investor ConferencesAMEX:BPABiosante Pharmaceuticals
14/11/200614:00Business WireBioSante Pharmaceuticals Reports Third Quarter 2006 Financial Results And Reviews Bio-E-Gel(R) Marketing AgreementAMEX:BPABiosante Pharmaceuticals
08/11/200613:45Business WireBioSante Pharmaceuticals Signs Bio-E-Gel(R) Marketing Agreement With Bradley Pharmaceuticals, Inc.AMEX:BPABiosante Pharmaceuticals
08/11/200613:45PR Newswire (US)Bradley Pharmaceuticals Enters Into Agreement With BioSante Pharmaceuticals for Estradiol Transdermal GelAMEX:BPABiosante Pharmaceuticals
03/11/200614:00Business WireBioSante Pharmaceuticals to Present at Rodman & Renshaw 8th Annual Healthcare ConferenceAMEX:BPABiosante Pharmaceuticals
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:BPA

La tua Cronologia

USOTC
LFSGS
Landa APP 2 (GM)
BIT
UC4KTU
Unicredit Bank
USOTC
VIVDS
RSE Collection (GM)
TSXV
LUKY
Luckystrike Resources
BITMOT
782402
Netherlands Tf 4% Ge37 Eur
EU
5883T
5883T
BOV
A1LB34R
Albemarle
EU
V173S
V173S
ASX
PVA
Psivida Corp
ASE
ADMIEE
Admie IPTO
NASDAQ
FMMMOX
Ameriprise Top Picks 202...
NASDAQ
AAECX
American Beacon AHL Targ...
USOTC
ALEGY
Allegro eu ()
BIT
P1Q0V9
BNP Paribas Issuance
BOV
TTEN3M
3TENTOS ON NM ON
COIN
PSCBTC
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network